Oper cat classic Model: 0037438; 0037448 মন্টিনিগ্রো - ক্রোয়েশীয় - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

oper cat classic model: 0037438; 0037448

druŠtvo za trgovinu na veliko farmaceutskim proizvodima "farmax" doo danilovgrad - medicinska sredstva za jednokratnu upotrebu

DiaStream Classic মন্টিনিগ্রো - ক্রোয়েশীয় - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

diastream classic

b. braun adria d.o.o. za proizvodnju, trgovinu i usluge dio stranog druŠtva u crnoj gori podgorica - medicinska sredstva za jednokratnu upotrebu

SERION ELISA classic Adenovirus IgM মন্টিনিগ্রো - ক্রোয়েশীয় - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

serion elisa classic adenovirus igm

druŠtvo sa ograniČenom odgovornoŠĆu "neomedica montenegro" za proizvodnju, promet i usluge, export-import podgorica - in vitro dijagnostička medicinska sredstva

CELLACARE GENUCAST MOD CLASSIC মন্টিনিগ্রো - ক্রোয়েশীয় - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

cellacare genucast mod classic

druŠtvo zaproizvodnju, promet posredovanje i usluge "nativa" doo budva - medicinska sredstva za pomoć licima sa invaliditetom

nitrylex classic মন্টিনিগ্রো - ক্রোয়েশীয় - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

nitrylex classic

tehmar promet doo beograd dio stranog druŠtva u podgorici - medicinska sredstva za jednokratnu upotrebu

Virbagen Omega ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

virbagen omega

virbac s.a. - rekombinantni omega interferon mačjeg podrijetla - Иммуностимуляторы, - dogs; cats - dogsreduction of mortality and clinical signs of parvovirosis (enteric form) in dogs from one month of age. catstreatment of cats infected with feline leukaemia virus (felv) and / or feline immunodeficiency virus (fiv), in non-terminal clinical stages, from the age of nine weeks. in a field study conducted, it was observed that there was:a reduction of clinical signs during the symptomatic phase (four months);a reduction of mortality:in anaemic cats, mortality rate of about 60% at four, six, nine and 12 months was reduced by approximately 30% following treatment with interferon;in non-anaemic cats, mortality rate of 50% in cats infected by felv was reduced by 20% following treatment with interferon. kod mačaka zaraženih virusom fiv, smrtnost je bila niska (5%) i nije bila pod utjecajem liječenja.